MNOVNasdaqPharmaceutical PreparationsFiscal year ends December 31
MEDICINOVA INC
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$1.40−0.02 (-1.41%)
Close on Oct 19, 2026
- Market cap
- $68.91M
- P/E (TTM)
- –
- Dividend yield
- –
SEC filings
40 of Medicinova's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Current report | 8-K | Sep 23, 2026 | Sep 28, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 31, 2026 | Sep 2, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 17, 2026 | Aug 19, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2026 | Aug 13, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 23, 2026 | Jun 24, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | May 14, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | Jun 23, 2026 | Apr 29, 2026 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2025 | Mar 10, 2026 | SEC EDGAR |
| Current report | 8-K | Feb 20, 2026 | Feb 20, 2026 | SEC EDGAR |
| Current report | 8-K | Dec 29, 2025 | Dec 30, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2025 | Nov 12, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2025 | Aug 14, 2025 | SEC EDGAR |
| Current report | 8-K | Jul 30, 2025 | Aug 1, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 17, 2025 | Jun 18, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2025 | May 13, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | Jun 17, 2025 | Apr 28, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 11, 2025 | Mar 11, 2025 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2024 | Feb 19, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2024 | Nov 13, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2024 | Aug 8, 2024 | SEC EDGAR |
| Current report | 8-K | Jun 11, 2024 | Jun 12, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2024 | May 9, 2024 | SEC EDGAR |
| Proxy statement | DEF 14A | Jun 11, 2024 | Apr 26, 2024 | SEC EDGAR |
| Current report | 8-K | Mar 26, 2024 | Apr 1, 2024 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2023 | Feb 15, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2023 | Nov 9, 2023 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2023 | Aug 9, 2023 | SEC EDGAR |
| Current report | 8-K | Aug 4, 2023 | Aug 7, 2023 | SEC EDGAR |
| Current report | 8-K | Jun 15, 2023 | Jun 22, 2023 | SEC EDGAR |
| Current report | 8-K | Jun 13, 2023 | Jun 14, 2023 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2023 | May 11, 2023 | SEC EDGAR |
| Current report | 8-K | Apr 20, 2023 | Apr 26, 2023 | SEC EDGAR |
| Proxy statement | DEF 14A | Jun 13, 2023 | Apr 26, 2023 | SEC EDGAR |
| Annual report, amended | 10-K/A | Dec 31, 2022 | Mar 28, 2023 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2022 | Feb 16, 2023 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2022 | Nov 10, 2022 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2022 | Aug 11, 2022 | SEC EDGAR |
| Current report | 8-K | Jun 16, 2022 | Jun 21, 2022 | SEC EDGAR |
| Current report | 8-K | Jun 14, 2022 | Jun 15, 2022 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2022 | May 12, 2022 | SEC EDGAR |